Dedifferentiation process driven by radiotherapy-induced HMGB1/TLR2/YAP/HIF-1α signaling enhances pancreatic cancer stemness
- Cell Death Dis. 2019 Sep 26;10(10):724. doi: 10.1038/s41419-019-1956-8.
- 1. The Affiliated Hospital of Jiangsu University, 212001, Zhenjiang, China.
- 2. School of Pharmaceutical Sciences (Shenzhen), SYSU, 518107, Shenzhen, China.
- 3. School of Medicine, Jiangsu University, 212013, Zhenjiang, China.
- 4. The First People's Hospital of Zhenjiang, 212001, Zhenjiang, China.
- 5. The Affiliated Hospital of Jiangsu University, 212001, Zhenjiang, China. [email protected].
- 6. The Affiliated Hospital of Jiangsu University, 212001, Zhenjiang, China. [email protected].
- 7. School of Pharmaceutical Sciences (Shenzhen), SYSU, 518107, Shenzhen, China. [email protected].
- 8. Faculty of Science and Engineering, ÅboAkademi University and Turku Centre for Biotechnology, FI-20520, Turku, Finland. [email protected].
- 9. The Affiliated Hospital of Jiangsu University, 212001, Zhenjiang, China. [email protected].
Differentiated Cancer cells reacquiring stem cell traits following radiotherapy may enrich Cancer Stem Cells and accelerate tumor recurrence and metastasis. We are interested in the mechanistic role of dying cells-derived HMGB1 in CD133- pancreatic Cancer cells dedifferentiation following radiotherapy. We firstly confirmed that X-ray irradiation induced differentiation of CD133- pancreatic Cancer cells, from either sorted from patient samples or established cell lines, into Cancer stem-like cells (iCSCs). Using an in vitro coculture model, X-ray irradiation induced dying cells to release HMGB1, which further promoted CD133- pancreatic Cancer cells regaining stem cell traits, such as higher sphere forming ability and expressed higher level of stemness-related genes and proteins. Inhibiting the expression and activity of HMGB1 attenuated the dedifferentiation stimulating effect of irradiated, dying cells on C133- pancreatic Cancer cells in vitro and in PDX models. Mechanistically, HMGB1 binding with TLR2 receptor functions in a paracrine manner to affect CD133- pancreatic Cancer cells dedifferentiation via activating Hippo-YAP pathway and HIF-1α expression in oxygen independent manner in vitro and in vivo. We conclude that X-ray irradiation induces CD133- pancreatic Cancer cell dedifferentiation into a CSC phenotype, and inhibiting HMGB1 may be a strategy to prevent CSC enrichment and further pancreatic carcinoma relapse.
-
Cat. No.Product NameDescriptionTargetResearch Area
-